Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
CALL
Apogee Enterprises
APOG
$886M
| $240K | ﹤0.01% |
5,800
+3,200
| +123% | +$155K |
|
4777
Barnes & Noble Education
BNED
$420M
| $240K | ﹤0.01% |
418
+205
| +96% | +$116K |
|
4778
CryoPort
CYRX
$776M
| $240K | ﹤0.01% |
18,693
+16,406
| +717% | +$234K |
|
4779
FB Financial Corp
FBK
$3.1B
| $240K | ﹤0.01% |
6,131
+5,158
| +530% | +$221K |
|
4780
nLIGHT
LASR
$3.02B
| $240K | ﹤0.01% |
10,818
+9,901
| +1,080% | +$310K |
|
|
VRN
4781
DELISTED
Veren
VRN
| $239K | ﹤0.01% |
37,853
+3,162
| +9% | +$20.8K |
|
|
ANAT
4782
DELISTED
American National Group, Inc. Common Stock
ANAT
| $239K | ﹤0.01% |
1,847
+1,559
| +541% | +$199K |
|
|
BREW
4783
DELISTED
Craft Brew Alliance, Inc.
BREW
| $239K | ﹤0.01% |
14,641
-2,928
| -17% | -$55.4K |
|
4784
Dime Commercial Bancshares
DCOM
$1.81B
| $238K | ﹤0.01% |
7,142
+4,128
| +137% | +$146K |
|
4785
PUT
Stratasys
SSYS
$788M
| $238K | ﹤0.01% |
10,300
-700
| -6% | -$15.8K |
|
4786
First Community Bankshares
FCBC
$934M
| $237K | ﹤0.01% |
6,998
+5,554
| +385% | +$184K |
|
4787
1-800-Flowers.com
FLWS
$258M
| $237K | ﹤0.01% |
20,005
+13,240
| +196% | +$172K |
|
4788
CALL
McCormick & Company Non-Voting
MKC
$14.7B
| $237K | ﹤0.01% |
3,600
-35,800
| -91% | -$2.21M |
|
|
RDFN
4789
PUT
DELISTED
Redfin
RDFN
| $237K | ﹤0.01% |
12,700
-25,900
| -67% | -$548K |
|
4790
PUT
Synaptics
SYNA
$4.23B
| $237K | ﹤0.01% |
5,200
-5,600
| -52% | -$266K |
|
4791
CALL
ScottsMiracle-Gro
SMG
$3.55B
| $236K | ﹤0.01% |
3,000
+1,500
| +100% | +$118K |
|
4792
B2Gold
BTG
$6.78B
| $234K | ﹤0.01% |
101,911
+100,274
| +6,125% | +$238K |
|
|
SNV
4793
CALL
DELISTED
Synovus
SNV
| $234K | ﹤0.01% |
5,100
-3,600
| -41% | -$181K |
|
4794
CALL
Sysco
SYY
$39.8B
| $234K | ﹤0.01% |
3,200
-22,200
| -87% | -$1.6M |
|
|
PENG
4795
Penguin Solutions Inc
PENG
$3.18B
| $234K | ﹤0.01% |
16,340
-17,478
| -52% | -$272K |
|
4796
CALL
America Movil
AMX
$70.5B
| $233K | ﹤0.01% |
14,500
-11,000
| -43% | -$186K |
|
4797
CALL
BioCryst Pharmaceuticals
BCRX
$2.47B
| $233K | ﹤0.01% |
30,600
+8,500
| +38% | +$57.1K |
|
|
MITT
4798
TPG Mortgage Investment Trust
MITT
$215M
| $232K | ﹤0.01% |
4,245
+3,559
| +519% | +$202K |
|
|
FISV
4799
PUT
Fiserv Inc
FISV
$29B
| $231K | ﹤0.01% |
2,800
-5,700
| -67% | -$447K |
|
|
OSB
4800
DELISTED
Norbord Inc.
OSB
| $231K | ﹤0.01% |
+6,961
| New | +$272K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.